| Reference(英) |
|
3282
Emoto N, Isozaki O, Ohmura E, Ito F, Tsushima T, Shizume K, Demura H, Toma H
Basic fibroblast growth factor (FGF-2) in renal cell carcinoma, which is indistinguishable from that in normal kidney, is involved in renal cell carcinoma growth.
J Urol
1994
152:1626-31
PubMed ID: 7523715
DOI: 10.1016/s0022-5347(17)32492-8
|
|
3285
Kitamura M, Shirasawa T, Mitarai T, Muramatsu T, Maruyama N
A retinoid responsive cytokine gene, MK, is preferentially expressed in the proximal tubules of the kidney and human tumor cell lines.
Am J Pathol
1993
142:425-31
PubMed ID: 8434639
|
|
3284
Nishimura N, Kanda S, Yogi Y, Kawamura M, Nakamura M, Hyakutake H, Kanetake H, Saito Y
Secretion of autocrine growth-promoting activity by renal-carcinoma cells treated with 5-fluorouracil.
Int J Cancer
1992
52:105-9
PubMed ID: 1500215
DOI: 10.1002/ijc.2910520119
|
|
3283
Ikemoto S, Hayahara N, Wada S, Nishio S, Maekawa M
Combined effect of tumor necrosis factor alpha and anticancer chemotherapeutic agents against human renal carcinoma cell lines.
Eur Urol
1991
19:236-9
PubMed ID: 1855530
DOI: 10.1159/000473628
|
| 利用者成果(英) |
|
19952
Watanabe F, Sato S, Hirose T, Endo M, Endo A, Ito H, Ohba K, Mori T, Takahashi K.
NRIP1 regulates cell proliferation in lung adenocarcinoma cells
J Biochem
2024
175(3):323-333
PubMed ID: 38102728
DOI: 10.1093/jb/mvad107
|
|
19780
Yuki Hasebe, Michio Naoe
Gamma-delta T cells are optimal immune cell carrier vehicles for adenovirus vector-based gene therapy
The Showa University Journal of Medical Sciences
2023
35:103-111
DOI: 10.15369/sujms.35.103
|
|
10005
Soki Kashima, Takuya Maeda, Kyoko Masuda, Seiji Nagano, Takamitsu Inoue, Masashi Takeda, Yuka Kono, Takashi Kobayashi, Shigeyoshi Saito, Takahiro Higuchi, Hiroshi Ichise, Yuka Kobayashi, Keiko Iwaisako, Koji Terada, Yasutoshi Agata, Kazuyuki Numakura, Mitsuru Saito, Shintaro Narita, Masaki Yasukawa, Osamu Ogawa, Tomonori Habuchi, Hiroshi Kawamoto
Cytotoxic T Lymphocytes Regenerated From iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model
iScience
2020
23(4):100998
PubMed ID: 32259478
DOI: 10.1016/j.isci.2020.100998
|
|
11922
Isono T, Suzaki M.
Analysis of the characteristics of chemotherapy-resistant renal cell carcinomas based on global transcriptional analysis of their tissues and cell lines.
PLoS ONE
2019
PubMed ID: 31774870
DOI: 10.1371/journal.pone.0225721
|
|
4371
Isono T, Chano T, Yoshida T, Kageyama S, Kawauchi A, Yonese J, Yuasa T.
Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas.
Oncotarget
2018
9(33):23091-23101
PubMed ID: 29796174
DOI: 10.18632/oncotarget.25214
|
|
7050
Kajiura K, Masuda K, Naruto T, Kohmoto T, Watabnabe M, Tsuboi M, Takizawa H, Kondo K, Tangoku A, Imoto I.
Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Oncotarget
2017
8:2890-2905
PubMed ID: 27926516
DOI: 10.18632/oncotarget.13761
|
|
9731
Mizutani N, Abe M, Matsuoka S, Kajino K, Wakiya M, Ohtsuji N, Hatano R, Morimoto C, Hino O.
Establishment of anti-mesothelioma monoclonal antibodies.
BMC Res Notes
2016
9:324
PubMed ID: 27342200
DOI: 10.1186/s13104-016-2128-x
|
|
9920
Isono T, Chano T, Yoshida T, Kageyama S, Kawauchi A, Suzaki M, Yuasa T.
Hydroxyl-HIF2-alpha is potential therapeutic target for renal cell carcinomas.
Am J Cancer Res
2016
6:2263-2276
PubMed ID: 27822416
|
|
9921
Marichal T, Gaudenzio N, El Abbas S, Sibilano R, Zurek O, Starkl P, Reber LL, Pirottin D, Kim J, Chambon P, Roers A, Antoine N, Kawakami Y, Kawakami T, Bureau F, Tam SY, Tsai M, Galli SJ.
Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasis.
J. Clin. Invest.
2016
126:4497-4515
PubMed ID: 27820702
DOI: 10.1172/JCI86359
|
|
6403
Terasaka N, Futai K, Katoh T, Suga H.
A human microRNA precursor binding to folic acid discovered by small RNA transcriptomic SELEX.
RNA
2016
22(12):1918-1928
PubMed ID: 27852928
DOI: 10.1261/rna.057737.116
|
|
3744
Nakamura R, Oyama T, Tajiri R, Mizokami A, Namiki M, Nakamoto M, Ooi A.
Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma.
Cancer Sci
2015
106(5):656-64
PubMed ID: 25726761
DOI: 10.1111/cas.12649
|
|
6384
Hidenori Kawashima Sakae Masaki Marie Kawamura
Induction of HLA‑A* 33‑restricted cytotoxic lymphocytes against renal cell carcinoma targeting galectin 9 and PINCH
Biomedical Reports
2014
2:809-812
PubMed ID: 25279150
DOI: 10.3892/br.2014.334
|
|
18125
Naoe M, Ogawa Y, Hasebe Y, Morita J, Shichijo T, Igarashi A, Fuji K, Iwamoto S, Suzuki T, Terao S.
Enhancement of IL-2-induced cytotoxicity by interferon-alpha in renal cell carcinoma
Oncol Res
2011
19(10-11):479-86
PubMed ID: 22715591
DOI: 10.3727/096504012x13285365944373
|
|
18311
Mitsuoka K, Miyoshi S, Kato Y, Murakami Y, Utsumi R, Kubo Y, Noda A, Nakamura Y, Nishimura S, Tsuji A.
Cancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+/peptide transporter
J Nucl Med
2008
49(4):615-22
PubMed ID: 18344442
DOI: 10.2967/jnumed.107.048231
|
|
5012
Kawakami T, Chano T, Minami K, Okabe H, Okada Y, Okamoto K.
Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma.
Hum Mol Genet
2006
15(6):821-30
PubMed ID: 16439445
DOI: 10.1093/hmg/ddl001
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト